journal article·2016-02-17Open access

Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis

Rahul Sharma, Tarun Garg, Amit K. Goyal, Goutam Rath

Abstract

The present study is designed to explore the localized delivery of fluconazole using mucoadhesive polymeric nanofibers. Drug-loaded polymeric nanofibers were fabricated by the electrospinning method using polyvinyl alcohol (PVA) as the polymeric constituent. The prepared nanofibers were found to be uniform, non-beaded and non-woven, with the diameter of the fibers ranging from 150 to 180 nm. Further drug release studies indicate a sustained release of fluconazole over a period of 6 h. The results of studies on anti-microbial activity indicated that drug-loaded polymeric nanofibers exhibit superior anti-microbial activity against Candida albicans, when compared to the plain drug.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India

References (57)

Show source-provided references
1. 10.1016/0021-9797(71)90241-410.1016/0021-9797(71)90241-4 ↗
2. 10.1097/01.AOG.0000140687.51048.7310.1097/01.AOG.0000140687.51048.73 ↗
3. 10.1016/S0032-3861(99)00550-910.1016/S0032-3861(99)00550-9 ↗
4. 10.1016/S0032-3861(98)00866-010.1016/S0032-3861(98)00866-0 ↗
5. Cai W, Gupta RB. 2000. Hydrogels. In: Kirk-Othmer Encyclopedia of Chemical Technology. New York: John Wiley & Sons, Inc: 367–410.
6. Chaudhary S · J Drug Target · 2014 · 1
7. 10.1016/S0032-3861(00)00250-010.1016/S0032-3861(00)00250-0 ↗
8. Dennerstein G. · Aust Fam Physician · 1998 · 27 · 363
9. 10.1016/j.ejps.2013.11.01610.1016/j.ejps.2013.11.016 ↗
10. 10.3109/21691401.2014.91671510.3109/21691401.2014.916715 ↗
11. 10.2174/2210304x1120204000510.2174/2210304x11202040005 ↗
12. 10.1517/17425247.2014.89101410.1517/17425247.2014.891014 ↗
13. 10.2174/2210303111303666001510.2174/22103031113036660015 ↗
14. 10.2174/2210304x1120204000310.2174/2210304x11202040003 ↗
15. 10.1615/CritRevTherDrugCarrierSyst.201401012210.1615/CritRevTherDrugCarrierSyst.2014010122 ↗
16. Garg T · Drug Deliv · 2014
17. 10.1615/CritRevTherDrugCarrierSyst.v29.i1.1010.1615/CritRevTherDrugCarrierSyst.v29.i1.10 ↗
18. 10.1615/CritRevTherDrugCarrierSyst.201300725910.1615/CritRevTherDrugCarrierSyst.2013007259 ↗
19. 10.1080/1064744030002551410.1080/10647440300025514 ↗
20. 10.1007/978-3-662-45775-7_410.1007/978-3-662-45775-7_4 ↗
21. Goyal G · Drug Deliv · 2013
22. 10.1615/CritRevTherDrugCarrierSyst.201400811710.1615/CritRevTherDrugCarrierSyst.2014008117 ↗
23. 10.1016/j.eurpolymj.2008.06.03210.1016/j.eurpolymj.2008.06.032 ↗
24. 10.1016/j.carbpol.2009.02.00810.1016/j.carbpol.2009.02.008 ↗
25. 10.1097/00007691-199208000-0000810.1097/00007691-199208000-00008 ↗
26. 10.3109/10717544.2014.92876010.3109/10717544.2014.928760 ↗
27. 10.3109/10717544.2014.93553110.3109/10717544.2014.935531 ↗
28. 10.2174/2210303111303666001810.2174/22103031113036660018 ↗
29. 10.1615/CritRevTherDrugCarrierSyst.201400828510.1615/CritRevTherDrugCarrierSyst.2014008285 ↗
30. Kaur M · Drug Deliv · 2014
31. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
32. 10.3109/21691401.2014.98430210.3109/21691401.2014.984302 ↗
33. 10.3109/10717544.2014.99348610.3109/10717544.2014.993486 ↗
34. 10.1016/j.biomaterials.2004.10.00710.1016/j.biomaterials.2004.10.007 ↗
35. 10.1002/bit.2135110.1002/bit.21351 ↗
36. 10.1016/j.biomaterials.2005.01.00210.1016/j.biomaterials.2005.01.002 ↗
37. 10.1016/j.biomaterials.2004.07.02610.1016/j.biomaterials.2004.07.026 ↗
38. 10.3109/10717544.2014.93553210.3109/10717544.2014.935532 ↗
39. 10.1021/ma020444a10.1021/ma020444a ↗
40. Modgill V · Artif Cells Nanomed Biotechnol · 2014 · 1
41. 10.1016/S0002-9378(85)80004-110.1016/S0002-9378(85)80004-1 ↗
42. 10.3109/21691401.2014.92787910.3109/21691401.2014.927879 ↗
43. 10.1002/marc.20040025310.1002/marc.200400253 ↗
44. Parnami N · Artif Cells Nanomed Biotechnol · 2013
45. 10.1142/589410.1142/5894 ↗
46. 10.1088/0957-4484/7/3/00910.1088/0957-4484/7/3/009 ↗
47. 10.3109/10717544.2014.94501810.3109/10717544.2014.945018 ↗
48. 10.1016/j.memsci.2008.05.06210.1016/j.memsci.2008.05.062 ↗
49. 10.1615/CritRevTherDrugCarrierSyst.201400819310.1615/CritRevTherDrugCarrierSyst.2014008193 ↗
50. 10.1016/S0032-3861(01)00540-710.1016/S0032-3861(01)00540-7 ↗
51. Singh B · Artif Cells Nanomed Biotechnol. · 2014 · 1
52. Singh H · Artif Cells Nanomed Biotechnol · 2014
53. Singh O · J Pharm · 2014 · 1
54. 10.1016/S0002-9378(98)80001-X10.1016/S0002-9378(98)80001-X ↗
55. 10.1098/rspa.1969.020510.1098/rspa.1969.0205 ↗
56. 10.1002/pi.159910.1002/pi.1599 ↗
57. 10.1016/j.eurpolymj.2004.10.02710.1016/j.eurpolymj.2004.10.027 ↗